会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
    • 使用四氢吲哚酮类似物和衍生物治疗认知/注意力缺陷障碍的方法
    • US20050096317A1
    • 2005-05-05
    • US11002329
    • 2004-12-01
    • Alvin GlaskyDavid FickDavid Helton
    • Alvin GlaskyDavid FickDavid Helton
    • A61P25/28C07D209/88A61K31/541A61K31/404A61K31/454A61K31/496A61K31/5377
    • C07D209/08C07D209/88
    • Methods for treating cognitive/attention deficit disorders in general using tetrahydroindolone derivatives and analogues, particularly tetrahydroindolone derivatives or analogues in which the tetrahydroindolone derivative or analogue is covalently linked to another moiety to form a bifunctional conjugate are disclosed. More specifically, methods and compositions for treating attention deficit disorder and attention deficit hyperactivity disorders in adults and children as well as mild cognitive impairment and dementia are provided. The compounds used to treat and/or palliate cognitive/attention deficit disorders in general include a tetrahydroindolone derivative or analogue comprises a 9-atom bicyclic moiety, moiety A, linked through a linker L to a moiety B, where B is a carboxylic acid, a carboxylic acid ester, or a moiety of the structure N(Y1)—D, where Y1 can be one of a variety of substituents, including hydrogen or alkyl, and D is a moiety that enhances the pharmacological effects, promotes absorption or blood-brain barrier penetration of the derivative or analogue. The moiety A has a six-membered ring fused to a five-membered ring. The moiety A can have one, two, or three nitrogen atoms in the five membered ring. The moiety A can be a tetrahydroindolone moiety. The moiety B can be one of a variety of moieties, including moieties having nootropic activity or other biological or physiological activity.
    • 公开了通常使用四氢吲哚酮衍生物和类似物,特别是其中四氢吲哚酮衍生物或类似物共价连接到另一部分以形成双功能缀合物的四氢吲哚酮衍生物或类似物的治疗认知/注意力缺陷障碍的方法。 更具体地,提供了用于治疗成人和儿童的注意力缺陷障碍和注意缺陷多动障碍以及轻度认知障碍和痴呆的方法和组合物。 用于治疗和/或缓解认知/注意力缺陷障碍的化合物通常包括四氢吲哚酮衍生物或类似物包含通过连接体L与B部分连接的9位双环部分A部分,其中B是羧酸, 羧酸酯或结构N(Y 1 H)-D的部分,其中Y 1可以是多种取代基之一,包括氢或烷基, 并且D是增强药理作用,促进衍生物或类似物的吸收或血脑屏障穿透的部分。 部分A具有与五元环稠合的六元环。 部分A可以在五元环中具有一个,两个或三个氮原子。 部分A可以是四氢吲哚酮部分。 部分B可以是多种部分之一,包括具有向异性活性或其他生物或生理活性的部分。
    • 8. 发明授权
    • Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
    • 使用四氢吲哚酮类似物和衍生物治疗认知/注意力缺陷障碍的方法
    • US06982269B2
    • 2006-01-03
    • US10193550
    • 2002-07-09
    • Alvin J. GlaskyDavid B. FickDavid Helton
    • Alvin J. GlaskyDavid B. FickDavid Helton
    • A61K31/52A61K31/495A61K43/54A61K31/33
    • C07D209/08C07D209/88
    • Methods for treating cognitive/attention deficit disorders in general using tetrahydroindolone derivatives and analogues, particularly tetrahydroindolone derivatives or analogues in which the tetrahydroindolone derivative or analogue is covalently linked to another moiety to form a bifunctional conjugate are disclosed. More specifically, methods and compositions for treating attention deficit disorder and attention deficit hyperactivity disorders in adults and children as well as mild cognitive impairment and dementia are provided. The compounds used to treat and/or palliate cognitive/attention deficit disorders in general include a tetrahydroindolone derivative or analogue comprises a 9-atom bicyclic moiety, moiety A, linked through a linker L to a moiety B, where B is a carboxylic acid, a carboxylic acid ester, or a moiety of the structure N(Y1)-D, where Y1 can be one of a variety of substituents, including hydrogen or alkyl, and D is a moiety that enhances the pharmacological effects, promotes absorption or blood-brain barrier penetration of the derivative or analogue. The moiety A has a six-membered ring fused to a five-membered ring. The moiety A can have one, two, or three nitrogen atoms in the five membered ring. The moiety A can be a tetrahydroindolone moiety. The moiety B can be one of a variety of moieties, including moieties having nootropic activity or other biological or physiological activity.
    • 公开了通常使用四氢吲哚酮衍生物和类似物,特别是其中四氢吲哚酮衍生物或类似物共价连接到另一部分以形成双功能缀合物的四氢吲哚酮衍生物或类似物的治疗认知/注意力缺陷障碍的方法。 更具体地,提供了用于治疗成人和儿童的注意力缺陷障碍和注意缺陷多动障碍以及轻度认知障碍和痴呆的方法和组合物。 用于治疗和/或缓解认知/注意力缺陷障碍的化合物通常包括四氢吲哚酮衍生物或类似物包含通过连接体L与B部分连接的9位双环部分A部分,其中B是羧酸, 羧酸酯或结构N(Y 1 H)-D的部分,其中Y 1可以是多种取代基之一,包括氢或烷基, 并且D是增强药理作用,促进衍生物或类似物的吸收或血脑屏障穿透的部分。 部分A具有与五元环稠合的六元环。 部分A可以在五元环中具有一个,两个或三个氮原子。 部分A可以是四氢吲哚酮部分。 部分B可以是多种部分之一,包括具有向异性活性或其他生物或生理活性的部分。
    • 10. 发明申请
    • METHODS FOR TREATING COGNITIVE /ATTENTION DEFICIT DISORDERS USING TETRAHYDROINDOLONE ANALOGUES AND DERIVATIVES
    • 使用四氢吲哚酮类似物和衍生物治疗认知/注意缺陷性疾病的方法
    • US20090192319A1
    • 2009-07-30
    • US12414539
    • 2009-03-30
    • Alvin J. GlaskyDavid B. FickDavid Helton
    • Alvin J. GlaskyDavid B. FickDavid Helton
    • C07D209/08
    • C07D209/08C07D209/88
    • Methods for treating cognitive/attention deficit disorders in general using tetrahydroindolone derivatives and analogues, particularly tetrahydroindolone derivatives or analogues in which the tetrahydroindolone derivative or analogue is covalently linked to another moiety to form a bifunctional conjugate are disclosed. More specifically, methods and compositions for treating attention deficit disorder and attention deficit hyperactivity disorders in adults and children as well as mild cognitive impairment and dementia are provided. The compounds used to treat and/or palliate cognitive/attention deficit disorders in general include a tetrahydroindolone derivative or analogue comprises a 9-atom bicyclic moiety, moiety A, linked through a linker L to a moiety B, where B is a carboxylic acid, a carboxylic acid ester, or a moiety of the structure N(Y1)-D, where Y1 can be one of a variety of substituents, including hydrogen or alkyl, and D is a moiety that enhances the pharmacological effects, promotes absorption or blood-brain barrier penetration of the derivative or analogue. The moiety A has a six-membered ring fused to a five-membered ring. The moiety A can have one, two, or three nitrogen atoms in the five membered ring. The moiety A can be a tetrahydroindolone moiety. The moiety B can be one of a variety of moieties, including moieties having nootropic activity or other biological or physiological activity.
    • 公开了通常使用四氢吲哚酮衍生物和类似物,特别是其中四氢吲哚酮衍生物或类似物共价连接到另一部分以形成双功能缀合物的四氢吲哚酮衍生物或类似物的治疗认知/注意力缺陷障碍的方法。 更具体地,提供了用于治疗成人和儿童的注意力缺陷障碍和注意缺陷多动障碍以及轻度认知障碍和痴呆的方法和组合物。 用于治疗和/或缓解认知/注意力缺陷障碍的化合物通常包括四氢吲哚酮衍生物或类似物包含通过连接体L与B部分连接的9位双环部分A部分,其中B是羧酸, 羧酸酯或结构N(Y1)-D的部分,其中Y1可以是各种取代基之一,包括氢或烷基,D是增强药理作用,促进吸收或血液中的部分, 衍生物或类似物的脑屏障穿透。 部分A具有与五元环稠合的六元环。 部分A可以在五元环中具有一个,两个或三个氮原子。 部分A可以是四氢吲哚酮部分。 部分B可以是多种部分之一,包括具有向异性活性或其他生物或生理活性的部分。